Personalized regimen for PCSK9 inhibitors: A therapeutic option that maintains efficacy and reduces costs
| Autor: | Michele Coceani, Francesco Sbrana, Maddalena Toma, Mascia Pianelli, Andrea Ripoli, Federico Bigazzi, R. Luciani, Tiziana Sampietro, Beatrice Dal Pino |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Male
medicine.medical_specialty Serine Proteinase Inhibitors Endocrinology Diabetes and Metabolism 030204 cardiovascular system & hematology Hyperlipoproteinemia Type II 03 medical and health sciences 0302 clinical medicine Text mining Internal Medicine Humans Medicine 030212 general & internal medicine Precision Medicine Intensive care medicine PCSK9 Inhibitors Nutrition and Dietetics business.industry Middle Aged Regimen Costs and Cost Analysis Health Resources Female Cardiology and Cardiovascular Medicine business |
| Zdroj: | Journal of Clinical Lipidology. 12:1324-1325 |
| ISSN: | 1933-2874 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect